First Page | Document Content | |
---|---|---|
Clinical research Design of experiments Organochlorides Clinical trial Pharmaceutical industry Pharmacology Ondansetron Schizophrenia Desvenlafaxine Psychiatry Chemistry Medicine | N022117 Asenapine Amend 3Add to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 240,31 KBShare Document on Facebook |